科帕控股 CPA 深 沪
等待开盘 04-02 09:30:00 美东时间
118.575
+4.965
+4.37%
华盛通- 最 高119.92
- 今 开115.865
- 成交量 45.97万股
- 最 低 115.865
- 昨 收 113.61
- 总市值 48.78亿
- 52周最高 154.70
- 市盈率 静 7.26
- 换手率 1.12%
- 52周最低 79.83
- 委 比 -76.08%
- 总股本 4113.86万
- 历史最高 154.70
- 量 比 1.34
- 振 幅 3.57%
- 历史最低 6.13
- 每 手 1
- 风险率 16.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Shares of airline companies are trading higher as oil prices pull back after President Trump floated a timeline for ending the Middle East conflict.
Shares of airline companies are trading higher as oil prices pull back after Pr...
今天 01:55
美股大行评级 | 能源股再或大行青睐！康菲石油、雪铁龙、埃克森美孚、响尾蛇能源等获上调目标价；Unity评级分歧大，大摩、美银上调，富国银行下调
今日重点评级关注：花旗：维持Biomea Fusion"买入"评级，目标价从6美元升至7美元；Chardan Capital：维持Hyperion DeFi"买入"评级，目标价从7.75美元升至8.25美元
03-30 11:49
美股大行评级 | 潜在涨幅499.25%！Cabaletta Bio获Guggenheim升目标价至16美元，维持"买入"评级
今日重点评级关注：Guggenheim：维持Cabaletta Bio"买入"评级，目标价从15美元升至16美元；HC Wainwright & Co.：维持Palvella Therapeutics"买入"评级，目标价从255美元升至270美元
03-25 10:31
Barclays Maintains Overweight on Copa Holdings, Lowers Price Target to $165
Barclays analyst Pablo Monsivais maintains Copa Holdings (NYSE:CPA) with a Overweight and lowers the price target from $185 to $165.
03-24 22:06
美股大行评级 | 超多下调！露露乐蒙、Oklo、腾讯音乐、Docusign、BOBS、Bicycle、Academy Sports等遭多家大行下调目标价
今日重点评级关注：花旗：维持Candel Therapeutics"买入"评级，目标价从22美元升至26美元；Chardan Capital：维持CervoMed"买入"评级，目标价从15美元升至21美元
03-19 14:31
Under the Radar: Where Growth, Income, and High Returns Actually Coexist
One of the most persistent myths in investing is that you have to choose betwee...
03-18 00:59
BRIEF-Copa Holdings Announces Monthly Traffic Statistics For February 2026
BRIEF-Copa Holdings Announces Monthly Traffic Statistics For February 2026 March 16 (Reuters) - Copa Holdings SA CPA.N : COPA HOLDINGS ANNOUNCES MONTHLY TRAFFIC STATISTICS FOR FEBRUARY 2026 COPA HOLDINGS SA - FEBRUARY 2026 LOAD FACTOR UP 0.4 P.P. TO 87.1% COPA HOLDINGS SA - FEBRUARY 2026 ASM UP 15.6
03-16 20:39
美股大行评级 | 潜在涨幅101%！甲骨文获花旗升目标价至320美元，维持"买入"评级
今日重点评级关注：Freedom Capital Markets：维持LifeMD"买入"评级，目标价从8美元升至10美元；Chardan Capital：维持Opus Genetics"买入"评级，目标价从9美元升至11美元
03-13 09:59
Evercore ISI Group Maintains Outperform on Copa Holdings, Lowers Price Target to $160
Evercore ISI Group analyst Duane Pfennigwerth maintains Copa Holdings (NYSE:CPA) with a Outperform and lowers the price target from $185 to $160.
03-12 21:08
Barclays Maintains Overweight on Copa Holdings, Raises Price Target to $185
Barclays analyst Pablo Monsivais maintains Copa Holdings (NYSE:CPA) with a Overweight and raises the price target from $150 to $185.
02-13 23:28
